Merck suffers late-stage blow to vorapaxar
January 18, 2011Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar
An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …
BMS and Sanofi recall 64 million Avalide tablets
January 18, 2011Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan
Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …
Merck taps Parexel to help it meet biosimilar ambitions
January 18, 2011Research and Development Merck & Co, Parexel, biosimilars
Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …
Top doctors believe PCTs should stay
January 17, 2011BMA, NHS, NHS reforms, PCTs, Royal College of GP
Leading GPs have criticised the government’s wide-ranging NHS reforms, saying minor structural changes are all the health service needs. A …
FDA issues Multaq liver warning
January 17, 2011Sales and Marketing FDA, Multaq, atrial fibrilation, dronedarone
US regulators have warned doctors and patients about the risk of severe liver injury associated with Sanofi-Aventis’ atrial fibrillation (AF) …
Digital Pharma: Sanofi launches diabetes blog
January 17, 2011Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes
Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …
Shire says new plant will add to Replagal, Vpriv capacity
January 17, 2011Manufacturing and Production Cerezyme, Replagal, Shire, Vpriv
UK drugmaker Shire has completed construction of a new manufacturing facility for its orphan disease drugs Replagal and Vpriv, and …
Roche finance chief steps down
January 17, 2011Sales and Marketing Alan Hippe, Erich Hunziker, Roche, appointment, sales and marketing
Roche’s chief financial officer Erich Hunziker is to retire at the end of March after ten years with the company. …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
Digital Pharma: NHS thrombosis e-learning
January 14, 2011Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism
The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …
Gates Foundation funds TB drug discovery
January 14, 2011Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis
Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …
GSK moves Crohn’s disease drug into phase III
January 14, 2011Research and Development ChemoCentryx, Crohn’s disease, GSK’786, GlaxoSmithKline, Traficet-EN
GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …
Publicis acquires French comms agency
January 14, 2011Medical Communications Digital District, François Sarkozy, Healthcare Consulting, In-Sync, Publicis Healthcare Consulting, Resolute Communications, Yannick Sabatin, publicis
Paris-based communications giant Publicis Groupe has bought a health comms agency set up by the brother of French president Nicolas …
Anti-cancer stem cell drug starts clinical trials
January 14, 2011Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers
OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …
Red Health boosts account team
January 14, 2011Medical Communications Jo Tubbs, Nicole Tripney, appointment, medical communications, red consultancy, red health
The Red Consultancy has started the year with two new hires for its specialist health team, Red Health. Account director …
End of the line for GSK’s resveratrol
January 14, 2011Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol
GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …
Watermeadow supports charity cycle ride
January 13, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …
Hanne Leth Hillman joins Zealand Pharma
January 13, 2011Medical Communications Hanne Leth Hillman, Zealand Pharma, appointment, medical communications
Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications. She will …
Aurobindo sells Chinese API unit to Sinopharm
January 13, 2011Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient
Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …
Learning from other healthcare models
January 13, 2011CapGemini, Kaiser Permanente, NHS, healthcare, integrated healthcare
When you need high quality healthcare that is also affordable, prevention is definitely better than cure. How can governments and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
